Markus Mapara
New York, New York, United States
Dr. Markus Mapara is a distinguished Professor of Medicine and the Director of the Bone Marrow Transplantation & Cell Therapy Program at Columbia University Medical Center.
With a strong focus on Plasma Cell Dyscrasias, Lymphomas, and Sickle Cell Anemia, Dr. Mapara treats patients undergoing autologous and allogeneic blood or marrow transplantation.
As a physician-scientist, he leads a research laboratory at Columbia Center for Translational Immunology, focusing on bone marrow transplantation and cellular therapy, particularly aiming to prevent GVHD and induce tolerance.
Dr. Mapara's leadership at Columbia University led to the successful establishment of a growing clinical BMT program, accreditation by FACT and NMDP, and the implementation of immune effector cell therapy.
His educational background includes graduating from the University of Heidelberg and receiving post-graduate training in Internal Medicine and Hematology/Oncology at various prestigious institutions, including the University Medical Center Charitè and Massachusetts General Hospital.
Prior to his current role, he served as the Director of the Adult HSCT Program at the University of Pittsburgh, a renowned program in Western Pennsylvania.
Dr. Mapara's vast experience also includes roles as FACT inspector and positions at Humboldt University of Berlin and Heidelberg University.
His expertise extends to offering antigen-specific and CAR T cell therapies in the Bone Marrow Transplantation Program at Columbia University, reflecting his commitment to advancing treatments and patient care.
